Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 5, 2011, Pages 651-664

  Cheung, Christine ^a   Sinha, Sanjay ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Human embryonic stem cell; Human IPS cell; Smooth muscle progenitor; Vascular regenerative medicines; Vascular smooth muscle

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA1 INTEGRIN; ALPHA5 INTEGRIN; BIOMATERIAL; CALPONIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DESMIN; HERMES ANTIGEN; MYOCARDIN; MYOSIN HEAVY CHAIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN P75; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX10; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT STEM CELL; ANGIOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL HETEROGENEITY; CELL MATURATION; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; CELL VIABILITY; EMBRYONIC STEM CELL; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIAL PROGENITOR CELL; HEART INFARCTION; HEMANGIOBLAST; HUMAN; LIMB ISCHEMIA; MESOANGIOBLAST; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; STROKE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRACKING; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; RATS; REGENERATION; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 80053274376     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.07.014     Document Type: Review

References (190)

1. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circ Res 2009, 105:724-736.
2. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
3. Kumar A.H.S., Caplice N.M. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 2010, 30:1080-1087.
4. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
5. Hellstrom M., Gerhardt H., Kalen M., Li X.R., Eriksson U., Wolburg H., et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001, 153:543-553.
6. Jain R.K. Molecular regulation of vessel maturation. Nat Med 2003, 9:685-693.
7. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
8. Hirschi K.K., DAmore P.A. Pericytes in the microvasculature. Cardiovasc Res 1996, 32:687-698.
9. Gerhardt H., Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003, 314:15-23.
10. Etchevers H.C., Vincent C., Le Douarin M., Couly G.F. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001, 128:1059-1068.
11. Vrancken Peeters M.-P.F.M., Gittenberger-de Groot A.C., Mentink M.M.T., Poelmann R.E. Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium. Anat Embryol 1999, 199:367-378.
12. Pouget C., Pottin K., Jaffredo T. Sclerotomal origin of vascular smooth muscle cells and pericytes in the embryo. Dev Biol 2008, 315:437-447.
13. Tsigkou O., Pomerantseva I., Spencer J.A., Redondo P.A., Hart A.R., O'Doherty E., et al. Engineered vascularized bone grafts. Proc Natl Acad Sci USA 2010, 107:3311-3316.
14. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005, 23:879-884.
15. Shepherd B.R., Jay S.M., Saltzman W.M., Tellides G., Pober J.S. Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. Tissue Eng Part A 2009, 15:165-173.
16. Foubert P., Matrone G., Souttou B., Lere-Dean C., Barateau V., Plouet J., et al. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 2008, 103:751-760.
17. Au P., Tam J., Fukumura D., Jain R.K. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008, 111:4551-4558.
18. Melero-Martin J.M., De Obaldia M.E., Kang S.Y., Khan Z.A., Yuan L., Oettgen P., et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 2008, 103:194-202.
19. L'Heureux N., McAllister T.N., de la Fuente L.M. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007, 357:1451-1453.
20. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009, 373:1440-1446.
21. Dahl S.L.M., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3.
22. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9-20.
23. Sanz-Ruiz R., Fernandez-Santos E., Dominguez-Munoa M., Parma R., Villa A., Fernandez L., et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant 2009, 18:245-254.
24. Lipinski M.J., Biondi-Zoccai G.G.L., Abbate A., Khianey R., Sheiban I., Bartunek J., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007, 50:1761-1767.
25. Bearzi C., Leri A., Lo Monaco F., Rota M., Gonzalez A., Hosoda T., et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci USA 2009, 106:15885-15890.
26. Smits A.M., van Laake L.W., den Ouden K., Schreurs C., Szuhai K., van Echteld C.J., et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 2009, 83:527-535.
27. Segers V.F.M., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
28. Liu JY P.H., Gopinath S., Tian J., Andreadis S.T. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng Part A 2010, 20:20.
29. Pacilli A., Pasquinelli G. Vascular wall resident progenitor cells. A review. Exp Cell Res 2009, 315:901-914.
30. Wu K.H., Zhou B., Yu C.T., Cui B., Lu S.H., Han Z.C., et al. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 2007, 83:1491-1500.
31. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
32. Jarajapu Y.P.R., Grant M.B. The promise of cell-based therapies for diabetic complications challenges and solutions. Circ Res 2010, 106:854-869.
33. Sorrentino S.A., Bahlmann F.H., Besler C., Muller M., Schulz S., Kirchhoff N., et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus - restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007, 116:163-173.
34. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor exhibit impaired proliferation, cells from type II diabetics adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
35. Valgimigli M., Rigolin G.M., Fucili A., Della Porta M., Soukhomovskaia O., Malagutti P., et al. CD34(+) and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004, 110:1209-1212.
36. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
37. Minamino T., Komuro I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med 2008, 5:637-648.
38. Dimmeler S., Vasa-Nicotera M. Aging of progenitor cells: limitation for regenerative capacity?. J Am Coll Cardiol 2003, 42:2081-2082.
39. Yamahara K., Sone M., Itoh H., Yamashita J.K., Yurugi-Kobayashi T., Homma K., et al. Augmentation of neovascularization corrected in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 2008, 3:e1666.
40. Kane N.M., Meloni M., Spencer H.L., Craig M.A., Strehl R., Milligan G., et al. Derivation of endothelial cells from human embryonic stem cells by directed differentiation analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2010, 30:1389-1397.
41. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
42. Levenberg S., Zoldan J., Basevitch Y., Langer R. Endothelial potential of human embryonic stem cells. Blood 2007, 110:806-814.
43. Li Z.J., Han Z.C., Wui J.C. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem 2009, 106:194-199.
44. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
45. Jiang X.B., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Development 2000, 127:1607-1616.
46. Wasteson P., Johansson B.R., Jukkola T., Breuer S., Akyürek L.M., Partanen J., et al. Developmental origin of smooth muscle cells in the descending aorta in mice. Development 2008, 135:1823-1832.
47. Gittenberger-de Groot A.C., Bartelings M.M., Deruiter M.C., Poelmann R.E. Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res 2005, 57:169-176.
48. Ema M., Takahashi S., Rossant J. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood 2006, 107:111-117.
49. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
50. Ema M., Faloon P., Zhang W.L., Hirashima M., Reid T., Stanford W.L., et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 2003, 17:380-393.
51. Kattman S.J., Huber T.L., Keller G.M. Multipotent Flk-1(+) cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006, 11:723-732.
52. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
53. Cai C.L., Liang X.Q., Shi Y.Q., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5:877-889.
54. Waldo K.L., Hutson M.R., Ward C.C., Zdanowicz M., Stadt H.A., Kumiski D., et al. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol 2005, 281:78-90.
55. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y.H., et al. Multipotent embryonic Isl1(+) progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
56. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S.J., Shao Y., et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-117.
57. Wu S.M., Fujiwara Y., Cibulsky S.M., Clapham D.E., Lien C.L., Schultheiss T.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
58. Christoforou N., Miller R.A., Hill C.M., Jie C.C., McCallion A.S., Gearhart J.D. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest 2008, 118:894-903.
59. Mikawa T., Gourdie R.G. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 1996, 174:221-232.
60. Cai C.L., Martin J.C., Sun Y.F., Cui L., Wang L.C., Ouyang K., et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 2008, 454:104-108.
61. Zhou B., Ma Q., Rajagopal S., Wu S.M., Domian I., Rivera-Feliciano J., et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008, 454:109-113.
62. Zhou B., von Gise A., Ma Q., Rivera-Feliciano J., Pu W.T. Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem Biophys Res Commun 2008, 375:450-453.
63. Red-Horse K., Ueno H., Weissman I.L., Krasnow M.A. Coronary arteries form by developmental reprogramming of venous cells. Nature 2010, 464:549-553.
64. Kennedy M., Firpo M., Chol K., Wall C., Robertson S., Kabrun N., et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 1997, 386:488-493.
65. Vogeli K.M., Jin S.W., Martin G.R., Stainier D.Y.R. A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 2006, 443:337-339.
66. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998, 125:725-732.
67. D'Souza S.L., Elefanty A.G., Keller G. SCL/Tal-1 is essential for hernatopoietic commitment of the hemangioblast but not for its development. Blood 2005, 105:3862-3870.
68. Lu S.J., Ivanova Y., Feng Q., Luo C.M., Lanza R. Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med 2009, 4:37-47.
69. Lancrin C., Sroczynska P., Stephenson C., Allen T., Kouskoff V., Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457:892-895.
70. Shin M., Nagai H., Sheng G. Notch mediates Wnt and BMP signals in the early separation of smooth muscle progenitors and blood/endothelial common progenitors. Development 2009, 136:595-603.
71. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 1995, 77:1-6.
72. Armstrong E.J., Bischoff J. Heart valve development - endothelial cell signaling and differentiation. Circ Res 2004, 95:459-470.
73. DeRuiter M.C., Poelmann R.E., VanMunsteren J.C., Mironov V., Markwald R.R., GittenbergerdeGroot A.C. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997, 80:444-451.
74. Hungerford J.E., Owens G.K., Argraves W.S., Little C.D. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 1996, 178:375-392.
75. Hall S.M., Hislop A.A., Pierce C.M., Haworth S.G. Prenatal origins of human intrapulmonary arteries formation and smooth muscle maturation. Am J Respir Cell Mol Biol 2000, 23:194-203.
76. Marchetti S., Gimond C., Iljin K., Bourcier C., Alitalo K., Pouyssegur J., et al. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J Cell Sci 2002, 115:2075-2085.
77. Hill K.L., Obrtlikova P., Alvarez D.F., King J.A., Keirstead S.A., Allred J.R., et al. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol 2010, 38:246-257.
78. Li Z.J., Wilson K.D., Smith B., Kraft D.L., Jia F.J., Huang M., et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 2009, 4:13.
79. Ferreira L.S., Gerecht S., Shieh H.F., Watson N., Rupnick M.A., Dallabrida S.M., et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle-like cells and form vascular networks in vivo. Circ Res 2007, 101:286-294.
80. Bai H., Gao Y.X., Arzigian M., Wojchowski D.M., Wu W.S., Wang Z.Z. BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J Cell Biochem 2010, 109:363-374.
81. Park S.-W., Koh Y.J., Jeon J., Cho Y.-H., Jang M.-J., Kang Y., et al. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of MEK/ERK and BMP4 signaling pathways. Blood 2010, 116:5762-5772.
82. Kokudo T., Suzuki Y., Yoshimatsu Y., Yamazaki T., Watabe T., Miyazono K. Snail is required for TGF beta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 2008, 121:3317-3324.
83. Arciniegas E., Frid M.G., Douglas I.S., Stenmark K.R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1-L8.
84. Esner M., Meilhac S.M., Relaix F., Nicolas J.F., Cossu G., Buckingham M.E. Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome. Development 2006, 133:737-749.
85. Pouget C., Gautier R., Teillet M.A., Jaffredo T. Somite-derived cells replace ventral aortic hemangioblasts and provide aortic smooth muscle cells of the trunk. Development 2006, 133:1013-1022.
86. Ben-Yair R., Kalcheim C. Notch and bone morphogenetic protein differentially act on dermomyotome cells to generate endothelium, smooth, and striated muscle. J Cell Biol 2008, 180:607-618.
87. De Angelis L., Berghella L., Coletta M., Lattanzi L., Zanchi M., Cusella-De Angelis M.G., et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 1999, 147:869-877.
88. Minasi M.G., Riminucci M., De Angelis L., Borello U., Berarducci B., Innocenzi A., et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002, 129:2773-2784.
89. Chen S.Y., Lechleider R.J. Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line. Circ Res 2004, 94:1195-1202.
90. Lee G., Kim H., Elkabetz Y., Al Shamy G., Panagiotakos G., Barberi T., et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 2007, 25:1468-1475.
91. Colleoni S., Galli C., Giannelli S.G., Armentero M.T., Blandini F., Broccoli V., et al. Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors. Exp Cell Res 2010, 316:1148-1158.
92. Zhou Y., Snead M.L. Derivation of cranial neural crest-like cells from human embryonic stem cells. Biochem Biophys Res Commun 2008, 376:542-547.
93. Li J., Zhu X.H., Chen M., Cheng L., Zhou D.Y., Lu M.M., et al. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci USA 2005, 102:8916-8921.
94. Oh J.Y., Richardson J.A., Olson E.N. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci USA 2005, 102:15122-15127.
95. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
96. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
97. Saiura A., Sata M., Hirata Y., et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7:382-383.
98. Hillebrands J.L., Klatter F.A., van den Hurk B.M.H., et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001, 107:1411-1422.
99. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
100. Caplice N.M., Bunch T.J., Stalboerger P.G., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003, 100:4754-4759.
101. Hu Y.H., Davison F., Ludewig B., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839.
102. Wagers A.J., Sherwood R.I., Christensen J.L., et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 279:2256-2259.
103. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
104. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
105. Rehman J., Li J.L., Orschell C.M., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
106. O'Neill T.J., Wamhoff B.R., Owens G.K., et al. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005, 97:1027-1035.
107. Bentzon J.F., Weile C., Sondergaard C.S., et al. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:2696-2702.
108. Hagensen M.K., Shim J., Thim T., et al. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121:898-905.
109. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
110. Prado-Lopez S., Conesa A., Arminan A., Martinez-Losa M., Escobedo-Lucea C., Gandia C., et al. Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 2010, 28:407-418.
111. Yu J., Huang N.F., Wilson K.D., Velotta J.B., Huang M., Li Z.J., et al. nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One 2009, 4:10.
112. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002, 99:4391-4396.
113. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X.Y., et al. Differentiation, survival, and function of embryonic stem cell-derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
114. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell-derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
115. Huang N.F., Niiyama H., Peter C., De A., Natkunam Y., Fleissner F., et al. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol 2010, 30:984-991.
116. Nourse M.B., Halpin D.E., Scatena M., Mortisen D.J., Tulloch N.L., Hauch K.D., et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells implications for tissue engineering. Arterioscler Thromb Vasc Biol 2010, 30:80-U189.
117. Xiao Q.Z., Zeng L.F., Zhang Z.Y., Margariti A., Ali Z.A., Channon K.M., et al. Sca-1(+) progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol 2006, 26:2244-2251.
118. Rufaihah A.J., Haider H.K., Heng B.C., Ye L., Tan R.S., Toh W.S., et al. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair. Regen Med 2010, 5:231-244.
119. Tian X., Hexum M.K., Penchev V.R., Taylor R.J., Shultz L.D., Kaufman D.S. Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells. Stem Cells (Miamisburg) 2009, 27:2675-2685.
120. Wang Z.Z., Au P., Chen T., Shao Y., Daheron L.M., Bai H., et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007, 25:317-318.
121. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Huber I., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007, 100:263-272.
122. Stevens K.R., Kreutziger K.L., Dupras S.K., Korte F.S., Regnier M., Muskheli V., et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 2009, 106:16568-16573.
123. Lesman A., Habib M., Caspi O., Gepstein A., Arbel G., Levenberg S., et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 2010, 16:115-125.
124. Gerecht-Nir S., Ziskind A., Cohen S., Itskovitz-Eldor J. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest 2003, 83:1811-1820.
125. Vallier L., Pedersen R. Differentiation of human embryonic stem cells in adherent and in chemically defined culture conditions. Curr Protoc Stem Cell Biol 2008, [Chapter 1:Unit 1D.4.1-D.4.7].
126. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O., Brinon B., et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 2010, 120:1125-1139.
127. Laugwitz K.L., Moretti A., Caron L., Nakano A., Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 2008, 135:193-205.
128. Kane N.M., Xiao Q., Baker A.H., Luo Z., Xu Q., Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol Ther 2011, 129:29-49.
129. Sinha S., Hoofnagle M.H., Kingston P.A., McCanna M.E., Owens G.K. Transforming growth factor-beta 1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004, 287:C1560-C1568.
130. Aikawa M., Sivam P.N., Kuroo M., Kimura K., Nakahara K., Takewaki S., et al. Human smooth-muscle myosin heavy-chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993, 73:1000-1012.
131. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
132. Drab M., Haller H., Bychkov R., Erdmann B., Lindschau C., Haase H., et al. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J 1997, 11:905-915.
133. vanderLoop F.T.L., Schaart G., Timmer E.D.J., Ramaekers F.C.S., vanEys G. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996, 134:401-411.
134. Hoggatt A.M., Simon G.M., Herring B.P. Cell-specific regulatory modules control expression of genes in vascular and visceral smooth muscle tissues. Circ Res 2002, 91:1151-1159.
135. Yamada T., Yoshikawa M., Takaki M., Torihashi S., Kato Y., Nakajima Y., et al. In vitro functional gut-like organ formation from mouse embryonic stem cells. Stem Cells 2002, 20:41-49.
136. Ueda T., Yamada T., Hokuto D., Koyama F., Kasuda S., Kanehiro H., et al. Generation of functional gut-like organ from mouse induced pluripotent stem cells. Biochem Biophys Res Commun 2010, 391:38-42.
137. Sinha S., Wamhoff B.R., Hoofnagle M.H., Thomas J., Neppl R.L., Deering T., et al. Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells 2006, 24:1678-1688.
138. Potta S.P., Liang H.M., Pfannkuche K., Winkler J., Chen S.H., Doss M.X., et al. Functional characterization and transcriptome analysis of embryonic stem cell-derived contractile smooth muscle cells. Hypertension 2009, 53:196-204.
139. Lindskog H., Athley E., Larsson E., Lundin S., Hellstrom M., Lindahl P. New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro. Arterioscler Thromb Vasc Biol 2006, 26:1457-1464.
140. Vo E., Hanjaya-Putra D., Zha Y.T., Kusuma S., Gerecht S. Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev Rep 2010, 6:237-247.
141. Sinha S., Hoofnagle M.H., Owens G.K. Derivation of contractile smooth muscle cells from embryonic stem cells. Methods Mol Biol 2009, 345-367.
142. Riegler J., Wells J.A., Kyrtatos P.G., Price A.N., Pankhurst Q.A., Lythgoe M.F. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 2010, 31:5366-5371.
143. Yurugi-Kobayashi T., Itoh H., Yamashita J., Yamahara K., Hirai H., Kobayashi T., et al. Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage. Blood 2003, 101:2675-2678.
144. Sone M., Itoh H., Yamahara K., Yamashita J.K., Yurugi-Kobayashi T., Nonoguchi A., et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 2007, 27:2127-2134.
145. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109:4761-4768.
146. Burchfield J.S., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008, 1:4.
147. Gnecchi M., Zhang Z.P., Ni A.G., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
148. Advanced cell technology receives FDA clearance for clinical trials using embryonic stem cells to treat age-related macular degeneration 2011, [p.]. http://www.advancedcell.com/news-and-media/press-releases/advanced-cell-technology-receives-fda-clearance-for-clinical-trials-using-embryonic-stem-cells-to-tre/.
149. Geron initiates clinical trial of human embryonic stem cell-based therapy [p.]. http://www.geron.com/media/pressview.aspx?id=1235.
150. Pearl J.I., Lee A.S., Leveson-Gower D.B., Sun N., Ghosh Z., Lan F., et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 2011, 8.
151. Taylor C.J., Bolton E.M., Pocock S., Sharples L.D., Pedersen R.A., Bradley J.A. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005, 366:2019-2025.
152. Lin G., Xie Y.B., OuYang Q., Qian X.B., Xie P.Y., Zhou X.Y., et al. HLA-matching potential of an established human embryonic stem cell bank in China. Cell Stem Cell 2009, 5:461-465.
153. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4:346-358.
154. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
155. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
156. Zhou H.Y., Wu S.L., Joo J.Y., Zhu S.Y., Han D.W., Lin T.X., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
157. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
158. Okita K., Hong H., Takahashi K., Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010, 5:418-428.
159. Warren L., Manos P.D., Ahfeldt T., Loh Y.-H., Li H., Lau F., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 5 Nov 2010, 7:1-13.
160. Ramos-Mejia V., Munoz-Lopez M., Garcia-Perez J.L., Menendez P. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 2010, 20:1092-1095.
161. Gore A., Li Z., Fung H.-L., Young J.E., Agarwal S., Antosiewicz-Bourget J., et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471.
162. Lowry W.E., Quan W.L. Roadblocks en route to the clinical application of induced pluripotent stem cells. J Cell Sci 2010, 123:643-651.
163. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010, 28:848-855.
164. Zhao T.B., Zhang Z.N., Rong Z.L., et al. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-U251.
165. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
166. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
167. Szabo E., Rampalli S., Risueno R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
168. James D., Nam H.S., Seandel M., Nolan D., Janovitz T., Tomishima M., et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF beta inhibition is Id1 dependent. Nat Biotechnol 2010, 28:161-166.
169. Seeger F.H., Zeiher A.M., Dimmeler S. Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 2007, 4(Suppl 1):S110-S113.
170. Luong E., Gerecht S. Stem cells and scaffolds for vascularizing engineered tissue constructs. Adv Biochem Eng Biotechnol 2009, 114:129-172.
171. Saif J., Schwarz T.M., Chau D.Y.S., Henstock J., Sami P., Leicht S.F., et al. Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol 2010, 30:1897-1904.
172. Kraehenbuehl T.P., Ferreira L.S., Zammaretti P., Hubbell J.A., Langer R. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009, 30:4318-4324.
173. Phelps E.A., Landazuri N., Thule P.M., Taylor W.R., Garcia A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci USA 2010, 107:3323-3328.
174. Kraehenbuehl T.P., Ferreira L.S., Hayward A.M., Nahrendorf M., van der Vlies A.J., Vasile E., et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011, 32:1102-1109.
175. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006, 27:5603-5617.
176. Guilak F., Cohen D.M., Estes B.T., Gimble J.M., Liedtke W., Chen C.S. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009, 5:17-26.
177. Xiong Q., Hill K.L., Li Q., Suntharalingam P., Mansoor A., Wang X., et al. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction LV remodeling. Stem Cells 2011, 29:367-375.
178. Ferreira L., Karp J.M., Nobre L., Langer R. New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 2008, 3:136-146.
179. Lau J.F., Anderson S.A., Adler E., Frank J.A. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol 2010, 7:97-105.
180. Kammili R.K., Taylor D.G., Xia J., Osuaka K., Thompson K., Menick D.R., et al. Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev Sep 2010, 19:1437-1448.
181. Cao F., Lin S., Xie X.Y., Ray P., Patel M., Zhang X.Z., et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006, 113:1005-1014.
182. Technology - clinical imaging of cell kinetics [p.]. http://www.cellsighttech.com/technology/clinical-imaging-fhbg.html.
183. Oyamada N., Itoh H., Sone M., Yamahara K., Miyashita K., Park K., et al. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J Transl Med 2008, 6.
184. Taura D., Sone M., Homma K., Oyamada N., Takahashi K., Tamura N., et al. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler Thromb Vasc Biol 2009, 29:1100-1103.
185. Moretti A., Bellin M., Jung C.B., Thies T.M., Takashima Y., Bernshausen A., et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1(+) cardiovascular progenitors. FASEB J 2010, 24:700-711.
186. Levenberg S., Ferreira L.S., Chen-Konak L., Kraehenbuehl T.P., Langer R. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat Protoc 2010, 5:1115-1126.
187. Lian Q.Z., Zhang Y.L., Zhang J.Q., Zhang H.K., Wu X.G., Zhang Y., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010, 121:1113-1123.
188. Huang H.R., Zhao X.L., Chen L.B., Xu C., Yao X., Lu Y.L., et al. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 2006, 351:321-327.
189. Xie C.Q., Zhang J., Villacorta L., Cui T., Huang H., Chen Y.E. A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol 2007, 27:E311-E312.
190. Lee T.H., Song S.H., Kim K.L., Yi J.Y., Shin G.H., Kim J.Y., et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 2010, 106:120-128.